Startup · $4m raised
Perth, WA
Every investor coverage indicates participated in a round SynGenis Pty Ltd raised.
Companies SynGenis Pty Ltd acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Thomas Hanly | Managing Director | Dealroom (Wed 23 Sep 2026), becomerichfaster.com, SMH Business, Dealroom (Mon 13 Jul 2026) |
Stories naming SynGenis Pty Ltd. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
A new precision-medicine company formed by Perth's Syngenis Labs, a research institute and two scientists has bought Gene S, maker of the Rosa pharmacogenomics tool; no price was disclosed.
SynGenis, a Perth biotech, has raised A$4 million in an oversubscribed pre-seed round arranged through Euroz Hartleys, to build an AI platform for RNA and DNA medicines ahead of a planned stock listing.
Roundup of Australian manufacturing news: OncoSil, K-TIG and Aurora Labs complete or commit raises, Amplia opens an offer, Siemens agrees to buy Altair, CSIRO unveils a printed-solar facility, and a WA medical alliance grows.
Western Australia's government has awarded $8.5 million in grants across three schemes, a health innovation seed fund, commercialisation bridge grants and innovation booster grants, naming dozens of local recipients.
Five WA medtech companies receive voucher grants from MTPConnect's WA Life Sciences Innovation Hub, sharing $450,000 matched by $600,000 in co-contributions to advance medical manufacturing projects.